Novalis LifeSciences — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Quanterixquanterix.com in 𝕏NASDAQ: QTRXJun 2017SEC filingmedium confidence

Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)Masoud Toloue(Former Chief Executive Officer)in

BoardJohn Connolly(Director)in Keith Crandell(Director)

Board seat Marijn Dekkers Paul Meister· per SEC Form D · $6.5M raise · filed Jul 2019

Co-investorsARCH Venture Partners Bain Capital Ventures Foothill Ventures Khosla Ventures In-Q-Tel

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.